acut
lower
respiratori
infect
alri
continu
import
caus
acut
ill
mortal
worldwid
especi
infant
young
children
global
burden
diseas
injuri
risk
factor
studi
gbd
estim
million
death
due
lower
respiratori
infect
global
total
death
incid
alri
children
age
less
year
estim
episod
per
childyear
case
progress
sever
episod
low
midincom
countri
case
occur
india
china
pakistan
bangladesh
indonesia
nigeria
main
etiolog
agent
respons
alri
includ
bacteria
streptococcu
pneumonia
haemophilu
influenza
type
b
staphylococcu
aureu
etc
virus
fungi
respiratori
syncyti
viru
rsv
human
influenza
virus
human
parainfluenza
virus
type
human
rhinovirus
hrv
adenovirus
adv
human
metapneumoviru
hmpv
human
coronaviru
hcov
human
bocaviru
hbov
identifi
among
patient
alri
china
alri
frequent
caus
child
mortal
despit
astonish
reduct
pneumoniaspecif
mortal
rate
per
live
birth
moreov
pneumonia
death
occur
poor
rural
commun
major
studi
contribut
data
epidemiolog
etiolog
agent
alri
industri
countri
although
sever
studi
report
preval
viral
infect
outpati
inpati
local
area
china
largescal
studi
across
multipl
provinc
season
previous
report
aim
identifi
viral
etiolog
associ
alri
patient
across
provinc
china
china
ministri
health
decid
sinc
data
patient
alri
part
continu
public
health
surveil
implement
nation
surveil
guidelin
parentsguardian
particip
studi
requir
provid
brief
verbal
consent
enrol
record
questionnair
physician
project
procedur
obtain
consent
approv
ethic
review
committe
chines
center
diseas
control
prevent
china
cdc
beij
china
initi
activ
surveil
hospit
alri
patient
sentinel
hospit
provinc
china
sentinel
site
chosen
care
consid
capac
surveil
laboratori
test
geograph
repres
nation
surveil
protocol
includ
guidelin
patient
enrol
specimen
collect
laboratori
test
case
report
form
protocol
data
transmiss
relat
standard
oper
procedur
sop
chines
languag
develop
chines
center
diseas
control
prevent
china
cdc
beij
region
refer
laboratori
protocol
use
particip
hospit
laboratori
patient
admit
ward
intens
care
unit
icu
depart
intern
medicin
pediatr
infecti
diseas
sentinel
hospit
screen
nurs
physician
alri
patient
consid
alri
least
one
list
manifest
acut
infect
measur
fever
abnorm
white
blood
cell
wbc
differenti
leukocytosi
wbc
count
leukopenia
wbc
count
less
chill
least
one
list
signssymptom
respiratori
tract
infect
cough
sputum
short
breath
lung
auscult
abnorm
rale
wheez
tachypnea
chest
pain
among
alri
patient
chest
radiograph
demonstr
punctat
patchi
uniform
densiti
opac
defin
radiograph
evid
pneumonia
week
month
first
alri
patient
enrol
specimen
collect
sentinel
hospit
base
predefin
target
sampl
size
case
screen
weekli
hospit
monthli
hospit
hospit
admiss
physician
obtain
verbal
consent
elig
alri
case
parentguardian
follow
appropri
respiratori
specimen
nasopharyng
swab
aspir
sputum
bronchoalveolar
lavag
lung
punctur
aspir
blood
serum
collect
respiratori
specimen
place
immedi
viral
transport
media
vtm
store
local
hospit
collect
blood
sampl
place
vacuum
blood
tube
ice
specimen
transfer
qualifi
laboratori
includ
central
region
refer
laboratori
local
laboratori
prefectur
provinci
level
diagnost
test
test
complet
within
hour
collect
laboratori
specimen
vtm
store
test
perform
within
hour
collect
specimen
test
seven
identifi
viral
etiolog
ie
rsv
human
influenza
viru
adv
human
parainfluenza
viru
piv
hmpv
hcov
hbov
viral
nucleic
acid
directli
extract
respiratori
specimen
use
commerci
kit
eg
qiampminielut
viru
spin
kit
qiaamp
viral
rna
mini
kit
rneasi
mini
kit
qiagen
valencia
ca
recommend
china
cdc
polymeras
chain
reaction
pcr
realtim
pcr
perform
detect
adv
hbov
revers
transcriptas
pcr
rtpcr
realtim
rtpcr
perform
detect
five
viral
agent
describ
previous
ig
ig
target
virus
detect
singl
blood
serum
specimen
ig
g
detect
pair
acut
convalesc
sera
enzymelink
immunosorb
assay
elisa
use
recommend
commerci
indirect
immunofluoresc
kit
xtag
respiratori
viral
panel
accord
manufactur
protocol
figur
assay
perform
biosafeti
level
facil
laboratori
laboratori
use
protocol
see
primer
sequenc
inform
tabl
tabl
file
undergo
qualiti
control
assess
china
cdc
one
target
virus
detect
specimen
patient
consid
posit
viral
etiolog
two
specimen
one
patient
test
one
test
posit
consid
patient
posit
viru
figur
case
singl
pathogen
identifi
label
monoinfect
case
two
virus
detect
regard
codetect
detail
demograph
clinic
data
case
laboratori
result
specimen
collect
staff
sentinel
hospit
laboratori
standard
case
report
form
enter
weekli
basi
onlin
data
manag
system
establish
china
cdc
use
descript
statist
summar
spectrum
viral
etiolog
age
group
hospit
alri
patient
analyz
tempor
trend
use
monthli
data
studi
period
statist
analysi
perform
spss
spss
chicago
il
usa
two
tail
mannwhitney
test
use
comparison
median
age
patient
posit
patient
neg
virus
fisher
least
signific
differ
lsd
test
use
multipl
comparison
median
age
patient
posit
differ
virus
chisquar
test
use
analyz
frequenc
data
p
consid
statist
signific
januari
hospit
alri
patient
contribut
specimen
enrol
sentinel
hospit
due
spars
patient
sentinel
hospit
includ
patient
sentinel
hospit
provinc
test
aforement
seven
viral
etiolog
final
analysi
figur
figur
among
alri
patient
children
age
year
elderli
age
year
median
age
year
interquartil
rang
iqr
year
temperatur
document
alri
case
time
physic
examin
cough
common
symptom
alri
patient
total
chest
xray
perform
report
radiograph
evid
pneumonia
tabl
hospit
alri
patient
test
seven
viral
etiolog
posit
least
one
etiolog
median
age
patient
consider
lower
patient
neg
virus
year
vs
year
p
mannwhitney
test
patient
virus
identifi
confirm
influenza
hcov
higher
median
age
year
patient
posit
virus
year
p
lsd
test
compar
patient
test
posit
viral
etiolog
patient
laboratori
confirm
influenza
hcov
frequent
complain
chest
pain
fatigu
similar
pattern
observ
adult
age
year
elderli
tabl
hospit
alri
patient
confirm
least
one
viral
etiolog
frequent
detect
viru
rsv
patient
follow
influenza
patient
piv
patient
adv
patient
hbov
patient
hmpv
patient
hcov
patient
tabl
codetect
found
patient
seven
viral
agent
detect
age
group
figur
howev
rsv
common
etiolog
young
children
age
year
alri
patient
figur
panel
influenza
virus
mainli
associ
alri
adult
year
elderli
year
year
throughout
studi
period
pandem
adult
year
alri
admiss
associ
influenza
figur
panel
b
piv
hbov
hmpv
infect
frequent
young
children
figur
panel
c
e
f
adv
infect
common
children
age
year
figur
panel
hcov
infect
evenli
distribut
allag
group
figur
panel
g
proport
respiratori
virus
alri
patient
demonstr
substanti
annual
variat
p
chisquar
test
mark
case
influenza
virus
much
higher
proport
rest
year
figur
panel
b
signific
increas
hbov
proport
observ
figur
panel
f
p
chisquar
test
among
alri
patient
codetect
two
virus
identifi
case
case
codetect
three
virus
detect
case
four
virus
detect
case
tabl
rsv
frequent
etiolog
case
codetect
rsv
anoth
respiratori
viru
detect
case
case
posit
combin
influenza
virus
case
piv
hbov
codetect
viral
pathogen
observ
case
case
hbov
monoinfect
period
clear
season
peak
rsv
influenza
piv
hbov
hmpv
infect
rsv
activ
observ
throughout
year
year
period
annual
peak
year
figur
panel
similarli
influenza
circul
observ
throughout
year
peak
autumnwint
peak
higher
influenza
circul
worldwid
spring
rel
lower
activ
observ
postpandem
season
figur
panel
b
piv
hbov
hmpv
infect
similar
pattern
one
peak
annual
peak
piv
hmpv
infect
observ
late
spring
season
hbov
peak
summer
figur
panel
c
e
f
clear
tempor
trend
patient
infect
adv
hcov
figur
panel
g
even
analysi
stratifi
age
group
figur
figur
studi
first
describ
viral
etiolog
hospit
alri
patient
use
data
sentinel
surveil
site
cover
major
chines
provinc
consecut
year
base
standard
surveil
protocol
laboratori
assay
total
hospit
alri
patient
enrol
posit
least
one
viru
consist
publish
data
report
china
countri
find
rsv
lead
pathogen
identifi
young
children
two
year
hospit
lower
respiratori
tract
infect
demonstr
rsv
could
also
associ
substanti
morbid
mortal
china
report
studi
industri
develop
countri
find
indic
prevent
strategi
rsv
immun
suitabl
vaccin
avail
futur
could
larg
public
health
impact
china
also
demonstr
influenza
virus
could
lead
substanti
burden
health
care
system
especi
larg
countri
like
china
rapidli
age
popul
especi
sinc
influenza
posit
rate
higher
adult
elderli
consist
report
estim
influenza
diseas
burden
base
studi
conduct
china
across
world
howev
influenza
vaccin
confer
individu
herd
immun
extrem
low
coverag
rate
china
widespread
use
influenza
vaccin
consider
impact
influenza
diseas
burden
china
piv
second
common
pathogen
identifi
children
age
less
year
also
observ
adv
import
viru
associ
alri
children
evid
import
china
public
health
author
guid
prioriti
control
infecti
diseas
public
health
perspect
inform
season
pathogen
crucial
inform
time
intervent
particularli
climat
econom
divers
countri
china
china
intens
nation
influenza
surveil
network
influenza
season
differ
epidemiolog
region
identifi
use
basi
optim
time
futur
vaccin
program
studi
demonstr
although
respiratori
virus
circul
throughout
year
virus
like
rsv
piv
hbov
hmpv
clear
season
trend
rsv
activ
peak
year
consist
publish
report
studi
temper
region
rsv
occur
frequent
winter
month
studi
limit
firstli
viral
pathogen
detect
studi
bacteri
pathogen
includ
prevent
us
get
comprehens
data
pathogen
associ
alri
mix
viralbacteri
infect
secondli
viru
sub
type
perform
systemat
sub
type
data
collect
data
import
could
provid
comprehens
pictur
age
group
season
variou
region
thirdli
understand
season
viral
agent
variou
climat
region
corel
meteorolog
data
temperatur
rainfal
humid
etc
import
better
understand
describ
epidemiolog
etiolog
relat
diseas
appropri
time
use
intervent
influenza
vaccin
futur
rsv
vaccin
fourthli
studi
includ
hrv
first
four
year
also
one
common
pathogen
associ
alri
import
virus
major
caus
alri
becom
increasingli
appar
sensit
detect
techniqu
greatli
improv
new
molecular
test
increasingli
replac
convent
method
howev
lack
control
limit
abil
infer
causal
associ
therefor
result
must
interpret
caution
conclus
studi
provid
import
background
inform
concern
respiratori
viral
etiolog
china
base
larg
sampl
size
across
vast
territori
multipl
season
find
could
serv
robust
evid
public
health
author
draw
plan
prevent
control
respiratori
viru
associ
alri
spectrum
viral
etiolog
could
help
estim
diseas
burden
associ
pathogen
guid
prioriti
futur
research
studi
alloc
resourc
fight
infecti
diseas
rsv
common
young
children
prevent
measur
vaccin
could
larg
public
health
impact
influenza
common
adult
influenza
vaccin
widespread
china
season
inform
could
use
basi
optim
time
potenti
use
appropri
pharmaceut
nonpharmaceut
intervent
diseas
preliminari
result
indic
robust
surveil
data
evalu
need
estim
diseas
burden
understand
whether
geograph
area
climat
environment
factor
pattern
human
behavior
influenc
time
sever
epidem
associ
viral
agent
